In low-flow, low-gradient aortic stenosis (LFLG AS), the severity of left ventricular dysfunction remains a key factor in the evaluation of aortic valve replacement.
P atients with aortic stenosis (AS) and left ventricular (LV) dysfunction, particularly those with a low-flow, low-gradient (LFLG) pattern, have greater perioperative risk and poorer outcomes.
1-4 Some analyses of retrospective data and the recent first report from the True or Pseudo-Severe Aortic Stenosis-Transcatheter Aortic Valve Implantation (TOPAS-TAVI) registry have shown acceptable early and late outcomes after transcatheter aortic valve replacement (TAVR) in patients with low-flow, low-gradient aortic stenosis (LFLG AS). [5] [6] [7] However, data on patients with severely depressed left ventricular ejection fraction (LVEF) (<30%) are scarce, and to our knowledge, no study to date has specifically focused on this challenging group of patients. The objective of this study was to determine the clinical outcomes and changes in LVEF over time in those patients with LFLG AS and LVEF less than 30%.
Methods
This was a multicenter registry including consecutive patients with LFLG AS undergoing TAVR procedures. Classic LFLG AS was defined by a mean transvalvular gradient less than 35 mm Hg, an effective orifice area less than 1.0 cm 2 ,
and an LVEF of 40% or less. The patients were part of a substudy of the TOPAS multicenter registry (NCT01835028). Patient enrollment and data collection started in January 2013, and patients were prospectively enrolled in 14 centers until March 2018. In addition, data from patients treated from 2007 to 2013 in 9 centers were collected retrospectively. Patients were separated into 2 groups according to baseline LVEF (as determined by echocardiography): less than 30% (n = 128 [43.7%]); very low LVEF group), and 30% or more (n = 165 [56.3%]; low LVEF group). Patients were followed up by clinical visits or telephone contact at 1 and 12 months and yearly thereafter. The ethics committee at each participating center approved the study, and written informed consent was obtained from all participants included prospectively; for those included retrospectively, consent was waived, according to institutional review board approval for the study.
Doppler Echocardiography
Patients underwent a transthoracic echocardiography exam pre-TAVR, at hospital discharge, and at 1 year post-TAVR. A dobutamine stress echocardiography (DSE) examination was performed at baseline in 92 of the 128 patients (71.2%) in the very low LVEF group, according to standard protocols. 8, 9 The presence of contractile reserve (or flow reserve) was defined as a percent increase in stroke volume of 20% or more during the DSE examination.
End Points
The end points were (1) changes in LVEF over time, per LVEF subgroups (very low LVEF vs low LVEF) and DSE examination results (presence vs absence of contractile reserve) and (2) mortality in the periprocedural (30-day) period and the remainder of the follow-up period, per LVEF subgroups.
Clinical events were recorded and defined according to the Valve Academic Research Consortium-2 consensus.
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Statistical Analysis
Continuous data were expressed as mean (SD) or median (interquartile range) and were tested for the normality of distribution with the Shapiro-Wilk test. Categorical data were expressed as number and percentage. Clinical and echocardiographic characteristics between groups were compared with the t test or the Wilcoxon rank sum test for continuous variables and with the χ 2 test or Fisher exact test for categorical variables. Kaplan-Meier curves and log-rank tests of the timeto-event data were used to evaluate overall and cardiac mortality, as well as stroke. An analysis of variance for repeatedmeasures model with interaction was used to analyze the changes in LVEF over time. Posterior comparisons were performed using the Tukey technique. All analyses were performed using a hierarchical method to account for betweencenter variability. A P value <.05 was considered statistically significant. Analyses were conducted using the statistical packages in SAS version 9.4 (SAS Institute Inc). Statistical analyses were performed from March 2018 to October 2018.
Results
Two hundred patients were enrolled at study centers and the retrospective data of an additional 93 individuals were added, leading to a total study population of 293 patients. Mean (SD) age was 80 (7) years, and 214 participants (73.0%) were men. Clinical, echocardiographic, and procedural characteristics of the study population, overall and according to LVEF, are shown in 
Clinical Outcomes
The 30-day mortality rate was 4.1% (12 of 293 participants), with no differences between groups (very low LVEF, 6 of 128 participants [4.7%]; low LVEF, 6 of 165 participants [3.6%]; P = .65). There were no differences between groups in the rate of periprocedural complications ( Figure, A. Overall, there was a significant increase in LVEF at 1-year follow-up (22% [95% CI, 18%-26%]; P < .001), and the increase was greater in the very low LVEF group (33% [95% CI, 25%-41%]; P < .001) compared with the low LVEF group (14% [95% CI, 10%-18%]; P < .001).
Data from the pre-TAVR DSE examinations performed in the very low LVEF group are summarized in Table 2 . At a mean (SD) dobutamine peak dose of 20 (6) μg/kg/min, mean (SD) aortic valve area was 0.83 (0.33) cm 2 , mean (SD) transvalvular gradient was 36 (10) mm Hg, and mean (SD) LVEF was 29% (8%). The mean (SD) values for stroke volume and stroke volume index at peak stress were 64 (21) mL and 35 (11) mL/m 2 , respectively. The mean percent increase in stroke volume was 22% (IQR, 2%-45%). A total of 47 patients (51.1%) had 20% or greater increase in stroke volume, consistent with the presence of contractile reserve. There were no differences in baseline clinical characteristics between patients with and without contractile reserve (eTable 2 in the Supplement Figure, B ). There were no differences between patients with very low LVEF with and without contractile reserve regarding early and late clinical events (eTable 3 in the Supplement).
Discussion
The main results of this study can be summarized as follows: in patients with low transvalvular gradient and severely depressed LVEF (in this study, with a mean LVEF of approximately 20%), (1) LVEF values significantly improved post-TAVR, with a mean LVEF greater than 30% at 1-year follow-up; (2) the presence or absence of contractile reserve during DSE pre-TAVR was not associated with LVEF changes over time or clinical outcomes; and (3) the periprocedural and long-term post-TAVR outcomes are similar to those in patients with mildly depressed LVEF. Patients with severe AS and depressed left ventricular function represent a minority (approximately 5%) of the population with AS. The initial report of the TOPAS-TAVI registry showed that patients with classic LFLG AS exhibited acceptable 2-year clinical outcomes, and the severity of LV dysfunction at baseline (with LVEF evaluated as a continuous variable) had no significant association with clinical outcomes or LVEF changes over time. 7 In this substudy from the TOPAS-TAVI (<30% vs Ն30%) ; The LVEF increased mean (SD) from 37% (7%) at baseline to 41% (12%) at 1-year follow-up in the group with LVEF of 30% or greater and from 22% (5%) to 34% (12%) in the group with LVEF less than 30% (P < .001). B, Changes in LVEF over time in patients with severe left ventricular dysfunction (LVEF<30%), according to the presence, absence, or unknown status of contractile reserve at dobutamine stress echocardiography before transcatheter aortic valve replacement; P < .001 for changes over time between groups. In patients with contractile reserve, the LVEF increased from a mean (SD) of 23% (5%) at baseline to 35% (12%) at 1-year follow-up (P < .001). In patients without contractile reserve, the LVEF increased from 21% (5%) at baseline to 33% (13%) at 1-year follow-up (P < .001). In patients with unknown contractile reserve, the LVEF increased from 22% (5%) at baseline to 35% (13%) at 1-year follow-up (P < .001). In line with these data, our results suggest that patients with LFLG AS and severely depressed LVEF at baseline derive greater benefit in terms of increase in LVEF compared with patients with mildly depressed LVEF. These changes were irrespective of the lack of contractile reserve determined by the DSE examination pre-TAVR. The initial report from the TOPAS-TAVI registry had already demonstrated the lack of association with the results of DSE on left ventricular function recovery and clinical outcomes, and the present study further extends these observations to those patients with very low LVEF. 7 Thus, in patients with LFLG AS, TAVR should not be declined on the basis of the severity of left ventricular dysfunction or the lack of contractile reserve at DSE. These results are also in accordance with prior studies in the SAVR and TAVR field, showing the lack of prognostic value of DSE in patients with LFLG AS.
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Limitations Whereas most patients were included in this registry prospectively, data were collected retrospectively in about onethird of the patients. Also, DSE examinations were not performed in 28% of the patients in the very low LVEF group, and no systematic data were obtained on Agatston calcium score and projected valve area. While patient characteristics were similar between groups, we cannot completely rule out some potential patient selection bias, particularly regarding the group of patients with very low LVEF. Finally, the results regarding clinical outcomes should be interpreted with caution because of the relative low number of patients included in both groups.
Conclusions
In patients with LFLG AS and severe left ventricular dysfunction, TAVR was feasible and was associated with similar clinical outcomes in those patients with only mildly depressed LVEF function. Importantly, most patients demonstrated a significant improvement in their LVEF over time, irrespective of the degree of baseline LV dysfunction and the presence or lack of contractile reserve. Thus, patients with LFLG severe AS should not be declined for aortic valve replacement procedures on the basis of the degree of LVEF dysfunction or the results of DSE. 
